Furthermore, inhibition of LZTS1 reduced the activity of AKT and its downstream target glycogen synthase kinase 3 β (GSK‐3β) in pancreatic cancer cells, while overexpressed LZTS1 led to upregulated activity of AKT and GSK‐3β. The gene discussed is LZTS1; the disease is familial pancreatic carcinoma.